HempMeds® Signs U.S. Manufacturer Sales Agreement For Over $2,500,000 – Ships First Two Months Supply of 12 Month Contract

Major New U.S. Manufacturer Actively Sources Cannabidiol (CBD) Hemp Oil – Gold Label Ingredient for Finished Product Production from HempMeds.com

San Diego, CA September 9, 2015 HempMeds®, a Medical Marijuana, Inc. (OTC Pink: MJNA) portfolio company and the Company’s master distributor, is pleased to announce to shareholders and the public that it has signed a U.S. manufacturer for sourcing of its Gold Label cannabidiol (CBD) hemp oil brand Real Scientific Hemp Oil™ (RSHO™). The sourcing agreement is for a minimum of $2,500,000 USD for a 12-month period. The first two months of the contract have already been sold, shipped and processed.

The new manufacturer has develop finished natural CBD hemp oil products for both people and pets – and represents an additional new revenue stream for the Company.

“The Company has been working diligently on developing the appropriate sales and distribution strategies,” states Stuart W. Titus, PhD and Chief Executive Officer of Medical Marijuana, Inc. “This is part of our strategy to scale and grow HempMeds’ sales and bring significant new revenue into the Company. This is the second major contract the company has executed in the past few months, first was the launch of Korea sales channels and this is the second. Our team has been working very hard to secure and develop additional large scale contracted supply agreements in order to diversify our sales channels.”

Hemp is widely regarded as a “whole food” and “super food.” MJNA’s cannabidiol (CBD) hemp oil is derived from the mature stalk of the hemp plant and is considered a food nutrient delivering the benefits of cannabinoids without the psychotropic/euphoric effects of THC.

An industry innovator and pioneer at the global level, HempMeds® is the primary sales and marketing arm for Medical Marijuana, Inc. Hemp oil products from HempMeds® are readily available to ship to all 50 U.S. states, districts and territories plus more than 40 countries around the world.

For more information on HempMeds and their all-natural hemp oil products, visit: https://hempmedspx.com. The Company invites the public to get involved in the conversation of the expanding cannabis industry with HempMeds® through the Company’s social media websites on Facebook and Twitter.

The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market.  For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s video statement, click here.

About HempMeds
HempMeds® offers mainstream marketing, sales, customer service, and logistics for the cannabis industry. HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC Pink: MJNA) and the Companys exclusive master distributor and contracted marketing company. In addition to handling sales and distribution, HempMeds® is the communication hub for the Medical Marijuana Inc. portfolio of companies.

About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For more information, please visit the company’s website at: www.MedicalMarijuanaInc.com

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

Medical Marijuana Inc. and HempMeds do not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.